Blood-conserving efficacy of multiple doses of oral tranexamic acid associated with an enhanced-recovery programme in primary total knee arthroplasty: a randomized controlled trial

Bone and Joint Journal

Volumn 100B, Issue 8, 2018, Pages 1025-1032

  Wang, D ^a   Wang, H Y ^a   Luo, Z Y ^a   Meng, W K ^a   Pei, F X ^a   Li, Q ^a   Zhou, Z K ^b   Zeng, W N ^c  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; DICLOFENAC; ENOXAPARIN; HEMOGLOBIN; RIVAROXABAN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ACTIVATED PARTIAL THROMBOPLASTIN TIME; ADULT; AGED; ARTICLE; BLOOD CONSERVATION; BLOOD TRANSFUSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENTERIC COATED TABLET; FEMALE; HEMOGLOBIN BLOOD LEVEL; HIDDEN BLOOD LOSS; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE DRUG DOSE; OPERATIVE BLOOD LOSS; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TOTAL KNEE ARTHROPLASTY; VENOUS THROMBOEMBOLISM; WOUND COMPLICATION; KNEE REPLACEMENT; LENGTH OF STAY; METABOLISM; OPERATION DURATION; ORAL DRUG ADMINISTRATION; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROCEDURES; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; DOUBLE-BLIND METHOD; FEMALE; HEMOGLOBINS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; OPERATIVE TIME; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 85051018067     PISSN: 20494394     EISSN: 20494408     Source Type: Journal    
DOI: 10.1302/0301-620X.100B8.BJJ-2017-1598.R1     Document Type: Article

References (41)

1. Yoshihara H, Yoneoka D. National trends in the utilization of blood transfusions in total hip and knee arthroplasty. J Arthroplasty 2014;29:1932–1937.
2. Blajchman MA, Beckers EA, Dickmeiss E, et al. Bacterial detection of platelets: current problems and possible resolutions. Transfus Med Rev 2005;19:259–272.
3. Fuller AK, Uglik KM, Savage WJ, Ness PM, King KE. Bacterial culture reduces but does not eliminate the risk of septic transfusion reactions to single-donor platelets. Transfusion 2009;49:2588–2593.
4. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011;1:CD001886.
5. Themistoklis T, Theodosia V, Konstantinos K, Georgios DI. Perioperative blood management strategies for patients undergoing total knee replacement: where do we stand now? World J Orthop 2017;8:441–454.
6. Su EP, Su S. Strategies for reducing peri-operative blood loss in total knee arthroplasty. Bone Joint J 2016;98-B(1 Suppl A):98–100.
7. Bedard NA, Pugely AJ, Lux NR, et al. Recent trends in blood utilization after primary hip and knee arthroplasty. J Arthroplasty 2017;32:724–727.
8. Sassoon A, Nam D, Jackups R, et al. Tranexamic acid: optimal blood loss management in surface replacement arthroplasty. Bone Joint J 2016;98-B:173–178.
9. Tengberg PT, Foss NB, Palm H, Kallemose T, Troelsen A. Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial. Bone Joint J 2016;98-B:747–753.
10. Pauzenberger L, Domej MA, Heuberer PR, et al. The effect of intravenous tranexamic acid on blood loss and early post-operative pain in total shoulder arthroplasty. Bone Joint J 2017;99-B:1073–1079.
11. Shin YS, Yoon JR, Lee HN, Park SH, Lee DH. Intravenous versus topical tranexamic acid administration in primary total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 2017;25:3585–3595.
12. Nielsen CS, Jans Ø, Ørsnes T, et al. Combined intra-articular and intravenous tranexamic acid reduces blood loss in total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. J Bone Joint Surg [Am] 2016;98-A:835–841.
13. Georgiadis AG, Muh SJ, Silverton CD, Weir RM, Laker MW. A prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 2013;28(Suppl):78–82.
14. Wong J, Abrishami A, El Beheiry H, et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg [Am] 2010;92-A:2503–2513.
15. Perreault RE, Fournier CA, Mattingly DA, Junghans RP, Talmo CT. Oral tranexamic acid reduces transfusions in total knee arthroplasty. J Arthroplasty 2017;32:2990–2994.
16. Irwin A, Khan SK, Jameson SS, et al. Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacement: results of 3000 procedures. Bone Joint J 2013;95-B:1556–1561.
17. Charoencholvanich K, Siriwattanasakul P. Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. Clin Orthop Relat Res 2011;469:2874–2880.
18. Yuan X, Li B, Wang Q, Zhang X. Comparison of 3 routes of administration of tranexamic acid on primary unilateral total knee arthroplasty: a prospective, randomized, controlled study. J Arthroplasty 2017;32:2738–2743.
19. Fillingham YA, Kayupov E, Plummer DR, et al. The James A. Rand Young Investigator's Award: a randomized controlled trial of oral and intravenous tranexamic acid in total knee arthroplasty: the same efficacy at lower cost? J Arthroplasty 2016;31(Suppl):26–30.
20. Luo ZY, Wang HY, Wang D, et al. Oral vs intravenous vs topical tranexamic acid in primary hip arthroplasty: a prospective, randomized, double-blind, controlled study. J Arthroplasty 2018;33:786–793.
21. Xie J, Ma J, Yao H, Yue C, Pei F. Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss after primary total knee arthroplasty without tourniquet: a randomized clinical trial. J Arthroplasty 2016;31:2458–2464.
22. Lei Y, Xie J, Xu B, et al. The efficacy and safety of multiple-dose intravenous tranexamic acid on blood loss following total knee arthroplasty: a randomized controlled trial. Int Orthop 2017;41:2053–2059.
23. Moher D, Schulz KF, Altman D, CONSORT Group. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001. Explore (NY) 2005;1:40–45.
24. Huang Z, Ma J, Shen B, Pei F. Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty 2014;29:2342–2346.
25. Li D, Tan Z, Kang P, Shen B, Pei F. Effects of multi-site infiltration analgesia on pain management and early rehabilitation compared with femoral nerve or adductor canal block for patients undergoing total knee arthroplasty: a prospective randomized controlled trial. Int Orthop 2017;41:75–83.
26. Wang D, Yang Y, Li Q, et al. Adductor canal block versus femoral nerve block for total knee arthroplasty: a meta-analysis of randomized controlled trials. Sci Rep 2017;7:40721.
27. Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology 1983;58:277–280.
28. Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery 1962;51:224–232.
29. No authors listed. Technical Specifications of Clinical Blood Transfusion. http://www.nhfpc.gov.cn/zwgkzt/wsbysj/200804/18676.shtml (date last accessed 5 June 2018).
30. Bruce DL, Eide KA, Smith NJ, Seltzer F, Dykes MH. Characteristics of the American Society of Anesthesiologists’ membership, 1967-1971. Anesthesiology 1974;41:67–70.
31. Yi Z, Bin S, Jing Y, et al. Tranexamic acid administration in primary total hip arthroplasty: a randomized controlled trial of intravenous combined with topical versus single-dose intravenous administration. J Bone Joint Surg [Am] 2016;98-A:983–991.
32. Huang ZY, Pei FX, Ma J, et al. Comparison of three different tourniquet application strategies for minimally invasive total knee arthroplasty: a prospective non-randomized clinical trial. Arch Orthop Trauma Surg 2014;134:561–570.
33. Xie J, Hu Q, Ma J, Huang Q, Pei F. Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss and the inflammatory response following enhanced-recovery primary total hip arthroplasty: a randomised clinical trial. Bone Joint J 2017;99-B:1442–1449.
34. Yue C, Kang P, Yang P, Xie J, Pei F. Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial. J Arthroplasty 2014;29:2452–2456.
35. Liu X, Zhang X, Chen Y, et al. Hidden blood loss after total hip arthroplasty. J Arthroplasty 2011;26:1100–1105.
36. Pilbrant A, Schannong M, Vessman J. Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol 1981;20:65–72.
37. Maniar RN, Kumar G, Singhi T, Nayak RM, Maniar PR. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res 2012;470:2605–2612.
38. Kayupov E, Fillingham YA, Okroj K, et al. Oral and intravenous tranexamic acid are equivalent at reducing blood loss following total hip arthroplasty: a randomized controlled trial. J Bone Joint Surg [Am] 2017;99-A:373–378.
39. Wang D, Zhu H, Meng WK, et al. Comparison of oral versus intra-articular tranexamic acid in enhanced-recovery primary total knee arthroplasty without tourniquet application: a randomized controlled trial. BMC Musculoskelet Disord 2018;19:85.
40. Wu YG, Zeng Y, Yang TM, et al. The efficacy and safety of combination of intravenous and topical tranexamic acid in revision hip arthroplasty: a randomized, controlled trial. J Arthroplasty 2016;31:2548–2553.
41. Kim TK, Chang CB, Kang YG, et al. Clinical value of tranexamic acid in unilateral and simultaneous bilateral TKAs under a contemporary blood-saving protocol: a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 2014;22:1870–1878.